Verici DX (VRCI) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Mar 2022 06:12 PM
RNS
Holding(s) in Company
21 Mar 2022 07:00 AM
RNS
Holding(s) in Company
18 Mar 2022 05:13 PM
RNS
Holding(s) in Company
16 Mar 2022 03:33 PM
RNS
Holding(s) in Company
15 Mar 2022 04:34 PM
RNS
Holding(s) in Company
11 Mar 2022 09:30 AM
RNS
Close of Subscription and Fundraise Update
04 Mar 2022 04:13 PM
RNS
Result of Fundraise
04 Mar 2022 12:20 PM
RNS
Close of Accelerated Bookbuild
04 Mar 2022 07:10 AM
RNS
Proposed Fundraise
15 Feb 2022 07:00 AM
RNS
Successful completion of analytical validation
14 Jan 2022 07:00 AM
RNS
Investor Presentation
12 Jan 2022 02:00 PM
RNS
Progress and strategy update
06 Jan 2022 07:00 AM
RNS
ClaravaT and TutevaT complete testing requirements
05 Jan 2022 07:00 AM
RNS
Collaboration with Illumina
04 Jan 2022 07:00 AM
RNS
Grant of two CPT Codes by AMA
17 Dec 2021 01:19 PM
RNS
Holding(s) in Company
08 Nov 2021 07:00 AM
RNS
Launch of Barbara T. Murphy Endowed Lectureship
01 Nov 2021 07:00 AM
RNS
Launch of Career Development Research Grant
13 Sep 2021 07:01 AM
RNS
Lorenzo Gallon, MD, Appointed as Chair of S.A.B
13 Sep 2021 07:00 AM
RNS
Half-year Report
06 Sep 2021 07:00 AM
RNS
Notice of Results
31 Aug 2021 07:00 AM
RNS
Patient enrolment completed
19 Aug 2021 07:00 AM
RNS
Appointment of Non-executive Director
27 Jul 2021 07:00 AM
RNS
Acceptance to CLIA Program
20 Jul 2021 07:00 AM
RNS
First European Clinical Trial Site Initiated
01 Jul 2021 04:56 PM
RNS
Directorate Change
24 Jun 2021 07:00 AM
RNS
Non-executive Director receives award
26 May 2021 04:41 PM
RNS
Second Price Monitoring Extn
26 May 2021 04:35 PM
RNS
Price Monitoring Extension
19 May 2021 03:14 PM
RNS
Result of AGM
05 May 2021 07:00 AM
RNS
Notice of Change of AGM Venue
29 Apr 2021 07:00 AM
RNS
Lease signed for laboratory
14 Apr 2021 07:01 AM
RNS
MTA secured to assess CTOT-19 samples
14 Apr 2021 07:00 AM
RNS
Final Results
13 Apr 2021 02:06 PM
RNS
Second Price Monitoring Extn
13 Apr 2021 02:01 PM
RNS
Price Monitoring Extension
13 Apr 2021 11:05 AM
RNS
Second Price Monitoring Extn
13 Apr 2021 11:00 AM
RNS
Price Monitoring Extension
17 Mar 2021 07:00 AM
RNS
Notice of Results
02 Mar 2021 07:00 AM
RNS
First clinical trial sites initiated in US
09 Feb 2021 07:00 AM
RNS
Capital Markets Day for Kidney Health
08 Feb 2021 07:00 AM
RNS
Accelerated CLIA approval strategy
05 Feb 2021 04:41 PM
RNS
Second Price Monitoring Extn
05 Feb 2021 04:36 PM
RNS
Price Monitoring Extension
18 Jan 2021 02:06 PM
RNS
Second Price Monitoring Extn
18 Jan 2021 02:00 PM
RNS
Price Monitoring Extension
18 Jan 2021 11:05 AM
RNS
Second Price Monitoring Extn
18 Jan 2021 11:01 AM
RNS
Price Monitoring Extension
15 Jan 2021 04:40 PM
RNS
Second Price Monitoring Extn
15 Jan 2021 04:35 PM
RNS
Price Monitoring Extension

Verici Dx is an immuno-diagnostics company that produces advanced clinical tests and organ transplant platforms for kidney transplant patients.

Verici Dx share price is listed in London under the ticker VRCI.

UK 100

Latest directors dealings